BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32267934)

  • 1. Triglycerides and remnant cholesterol associated with risk of aortic valve stenosis: Mendelian randomization in the Copenhagen General Population Study.
    Kaltoft M; Langsted A; Nordestgaard BG
    Eur Heart J; 2020 Jun; 41(24):2288-2299. PubMed ID: 32267934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma lipids and risk of aortic valve stenosis: a Mendelian randomization study.
    Nazarzadeh M; Pinho-Gomes AC; Bidel Z; Dehghan A; Canoy D; Hassaine A; Ayala Solares JR; Salimi-Khorshidi G; Smith GD; Otto CM; Rahimi K
    Eur Heart J; 2020 Oct; 41(40):3913-3920. PubMed ID: 32076698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity as a Causal Risk Factor for Aortic Valve Stenosis.
    Kaltoft M; Langsted A; Nordestgaard BG
    J Am Coll Cardiol; 2020 Jan; 75(2):163-176. PubMed ID: 31948645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low nonfasting triglycerides and reduced all-cause mortality: a mendelian randomization study.
    Thomsen M; Varbo A; Tybjærg-Hansen A; Nordestgaard BG
    Clin Chem; 2014 May; 60(5):737-46. PubMed ID: 24436475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of low-density lipoprotein cholesterol-related genetic variants with aortic valve calcium and incident aortic stenosis.
    Smith JG; Luk K; Schulz CA; Engert JC; Do R; Hindy G; Rukh G; Dufresne L; Almgren P; Owens DS; Harris TB; Peloso GM; Kerr KF; Wong Q; Smith AV; Budoff MJ; Rotter JI; Cupples LA; Rich S; Kathiresan S; Orho-Melander M; Gudnason V; O'Donnell CJ; Post WS; Thanassoulis G;
    JAMA; 2014 Nov; 312(17):1764-71. PubMed ID: 25344734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma adiponectin levels and risk of heart failure, atrial fibrillation, aortic valve stenosis, and myocardial infarction: large-scale observational and Mendelian randomization evidence.
    Nielsen MB; Çolak Y; Benn M; Mason A; Burgess S; Nordestgaard BG
    Cardiovasc Res; 2024 Feb; 120(1):95-107. PubMed ID: 37897683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular Disease.
    Castañer O; Pintó X; Subirana I; Amor AJ; Ros E; Hernáez Á; Martínez-González MÁ; Corella D; Salas-Salvadó J; Estruch R; Lapetra J; Gómez-Gracia E; Alonso-Gomez AM; Fiol M; Serra-Majem L; Corbella E; Benaiges D; Sorli JV; Ruiz-Canela M; Babió N; Sierra LT; Ortega E; Fitó M
    J Am Coll Cardiol; 2020 Dec; 76(23):2712-2724. PubMed ID: 33272365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated Lipoprotein(a) Does Not Cause Low-Grade Inflammation Despite Causal Association With Aortic Valve Stenosis and Myocardial Infarction: A Study of 100,578 Individuals from the General Population.
    Langsted A; Varbo A; Kamstrup PR; Nordestgaard BG
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2690-9. PubMed ID: 25938632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated remnant cholesterol, plasma triglycerides, and cardiovascular and non-cardiovascular mortality.
    Wadström BN; Pedersen KM; Wulff AB; Nordestgaard BG
    Eur Heart J; 2023 Apr; 44(16):1432-1445. PubMed ID: 36631967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of remnant cholesterol to cardiovascular risk.
    Langsted A; Madsen CM; Nordestgaard BG
    J Intern Med; 2020 Jul; 288(1):116-127. PubMed ID: 32181933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation.
    Varbo A; Benn M; Tybjærg-Hansen A; Nordestgaard BG
    Circulation; 2013 Sep; 128(12):1298-309. PubMed ID: 23926208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A third of nonfasting plasma cholesterol is in remnant lipoproteins: Lipoprotein subclass profiling in 9293 individuals.
    Balling M; Langsted A; Afzal S; Varbo A; Davey Smith G; Nordestgaard BG
    Atherosclerosis; 2019 Jul; 286():97-104. PubMed ID: 31108411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction.
    Jørgensen AB; Frikke-Schmidt R; West AS; Grande P; Nordestgaard BG; Tybjærg-Hansen A
    Eur Heart J; 2013 Jun; 34(24):1826-33. PubMed ID: 23248205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PCSK9 R46L Loss-of-Function Mutation Reduces Lipoprotein(a), LDL Cholesterol, and Risk of Aortic Valve Stenosis.
    Langsted A; Nordestgaard BG; Benn M; Tybjærg-Hansen A; Kamstrup PR
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3281-7. PubMed ID: 27218270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remnant cholesterol as a causal risk factor for ischemic heart disease.
    Varbo A; Benn M; Tybjærg-Hansen A; Jørgensen AB; Frikke-Schmidt R; Nordestgaard BG
    J Am Coll Cardiol; 2013 Jan; 61(4):427-436. PubMed ID: 23265341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated lipoprotein(a) in mitral and aortic valve calcification and disease: The Copenhagen General Population Study.
    Kaltoft M; Sigvardsen PE; Afzal S; Langsted A; Fuchs A; Kühl JT; Køber L; Kamstrup PR; Kofoed KF; Nordestgaard BG
    Atherosclerosis; 2022 May; 349():166-174. PubMed ID: 34903381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women.
    Nordestgaard BG; Benn M; Schnohr P; Tybjaerg-Hansen A
    JAMA; 2007 Jul; 298(3):299-308. PubMed ID: 17635890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Variants Associated With Increased Plasma Levels of Triglycerides, via Effects on the Lipoprotein Lipase Pathway, Increase Risk of Acute Pancreatitis.
    Hansen SEJ; Madsen CM; Varbo A; Tybjærg-Hansen A; Nordestgaard BG
    Clin Gastroenterol Hepatol; 2021 Aug; 19(8):1652-1660.e6. PubMed ID: 32801009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remnant cholesterol, LDL cholesterol, and apoB absolute mass changes explain results of the PROMINENT trial.
    Doi T; Langsted A; Nordestgaard BG
    Atherosclerosis; 2024 Jun; 393():117556. PubMed ID: 38678642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated remnant cholesterol in 25-hydroxyvitamin D deficiency in the general population: Mendelian randomization study.
    Ooi EM; Afzal S; Nordestgaard BG
    Circ Cardiovasc Genet; 2014 Oct; 7(5):650-8. PubMed ID: 25065375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.